Baldwin Wealth Partners’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
CCM
GCM
CAM
RIM
Baldwin Wealth Partners's LMAT Position: Q1 2025 in Review
Baldwin Wealth Partners sold out of LeMaitre Vascular (LMAT) in Q1 2025, closing a stake of 2,961 shares — an estimated $273K sold.
Baldwin Wealth Partners first reported a position in LMAT in Q3 2024 and held it in 2 quarters. The position peaked at $742K in Q3 2024. 288 funds tracked by Wall St. Rank hold LMAT as of Q1 2025.
- Baldwin Wealth Partners reported no remaining LeMaitre Vascular position as of Q1 2025 after selling out during the quarter.
- Baldwin Wealth Partners sold 2,961 LeMaitre Vascular shares in Q1 2025, an estimated $273K.
- Baldwin Wealth Partners first reported a position in LeMaitre Vascular in Q3 2024 and held it in 2 quarters.
- Baldwin Wealth Partners's LeMaitre Vascular position peaked at $742K in Q3 2024.
- 288 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2025.
Based on Baldwin Wealth Partners's 13F filing for Q1 2025, filed 14 Apr 2025.